natgillin/translations-raw huggingface dataset:
We propose that such deepened control should cover complete exploration of all circumstances and also publication of fraudulent activities and other offences harming the financial interests of the EU.’
Predlagamo, da bi moral takšen poglobljen nadzor zajemati celovito raziskovanje vseh okoliščin in tudi objavo goljufivih dejanj in drugih kaznivih dejanj, ki škodijo finančnim interesom EU.“
The citizens' committee has been formed and the contact persons have been designated in accordance with Article 3(2) of the Regulation and the proposed citizens' initiative is neither manifestly abusive, frivolous or vexatious nor manifestly contrary to the values of the Union as set out in Article 2 of the Treaty on European Union (TEU).
V skladu s členom 3(2) Uredbe je bil ustanovljen državljanski odbor in imenovani sta bili kontaktni osebi, predlagana državljanska pobuda pa ni očitno žaljiva, neresna ali provokativna in ni v očitnem nasprotju z vrednotami Unije, kot so določene v členu 2 Pogodbe o Evropski uniji (PEU).
Legal acts of the Union for the purpose of implementing the Treaties can be adopted
Za izvajanje Pogodb se lahko sprejmejo pravni akti Unije:
in order to define the tasks, priority objectives and the organisation of the Structural Funds which may involve grouping the Funds, in accordance with Article 177 of the Treaty on the Functioning of the European Union (TFEU);
da se opredelijo naloge, prednostni cilji in organizacija strukturnih skladov, ki lahko vključujejo združevanje skladov, v skladu s členom 177 Pogodbe o delovanju Evropske unije (PDEU);
for the adoption of a multiannual framework programme setting out all the activities of the Union in the field of research and technological development; the specific programmes developed within each activity of the multiannual framework programme; and the implementation of the multiannual framework programme, in accordance with Articles 182 and 183 TFEU;
za sprejetje večletnega okvirnega programa, v katerem so opredeljene vse dejavnosti Unije na področju raziskav in tehnološkega razvoja, posebnih programov, pripravljenih znotraj posamezne dejavnosti večletnega okvirnega programa, in za izvajanje večletnega okvirnega programa, v skladu s členoma 182 in 183 PDEU;
on the financial rules which determine in particular, inter alia, the procedures for implementing the budget of the Union, in accordance with Article 322 TFEU;
o finančnih pravilih, ki med drugim zlasti določajo postopke za izvrševanje proračuna Unije v skladu s členom 322 PDEU;
in the fields of the prevention of and the fight against fraud affecting the financial interests of the Union with a view to affording effective and equivalent protection in the Member States and in all the Union's institutions, bodies, offices and agencies, in accordance with Article 325 TFEU.
na področjih preprečevanja goljufij, ki škodijo finančnim interesom Unije, in boja proti njim, da bi se omogočila učinkovita in enakovredna zaščita v državah članicah ter v vseh institucijah, organih, uradih in agencijah Unije v skladu s členom 325 PDEU.
Deciding on whether or not to participate in an enhanced cooperation, such as the enhanced cooperation that established the European Public Prosecutor's Office, is a voluntary choice for each Member State.
Udeležba v okrepljenem sodelovanju, kot je okrepljeno sodelovanje, s katerim je bilo vzpostavljeno Evropsko javno tožilstvo, je prostovoljna izbira za vsako državo članico.
Therefore, legal acts of the Union for the purpose of implementing the Treaties should not, as a matter of principle, differentiate between Member States solely according to their participation or non-participation in an enhanced cooperation.
Zato pravni akti Unije za namen izvajanja Pogodb načeloma ne bi smeli razlikovati med državami članicami izključno glede na njihovo udeležbo ali neudeležbo v okrepljenem sodelovanju.
Nevertheless, the implementation of legal acts of the Union may differentiate between Member States when this is objectively justified, for example when, all relevant elements taken into account, there would exist, in practice, a different level of protection of the financial interests of the Union between Member States.
Vendar pa lahko pri izvajanju pravnih aktov Unije pride do razlikovanja med državami članicami, če je objektivno upravičeno, na primer, če bi ob upoštevanju vseh pomembnih elementov v praksi med državami članicami obstajala drugačna raven zaščite finančnih interesov Unije.
The TEU reinforces citizenship of the Union and enhances further the democratic functioning of the Union by providing, inter alia, that every citizen is to have the right to participate in the democratic life of the Union by way of a European citizens' initiative.
PEU krepi državljanstvo Unije in nadalje krepi demokratično delovanje Unije, tako da med drugim določa, da ima vsak državljan pravico sodelovati v demokratičnem življenju Unije prek evropske državljanske pobude.
For those reasons, the proposed citizens' initiative entitled ‘STOP FRAUD and abuse of EU FUNDS — by better control of decisions, implementation and penalties’ does not fall manifestly outside of the framework of the Commission's powers to submit a legal acts of the Union for the purpose of implementing the Treaties in accordance with Article 4(2)(b) and should therefore be registered.
Iz teh razlogov predlagana državljanska pobuda z naslovom „USTAVIMO GOLJUFIJE in zlorabo SREDSTEV EU – z boljšim nadzorom nad odločitvami, izvajanjem in kaznimi“ ne sodi očitno izven okvira pooblastil Komisije, da predlaga pravne akte Unije za namen izvajanja Pogodb v skladu s členom 4(2)(b), in bi jo bilo zato treba prijaviti.
Statements of support for this proposed citizens' initiative should be collected inasmuch as it aims at proposals from the Commission for legal acts of the Union for the purpose of implementing the Treaties which — while enhancing the protection of the financial interests of the Union — do not differentiate between Member States solely according to their participation or non-participation in the enhanced cooperation on the establishment of the European Public Prosecutor's Office.
Izjave o podpori tej predlagani državljanski pobudi bi bilo treba zbrati, v kolikor je njen cilj, da Komisija predlaga pravne akte Unije za izvajanje Pogodb, ki ob krepitvi zaščite finančnih interesov Unije ne razlikujejo med državami članicami izključno glede na njihovo udeležbo ali neudeležbo v okrepljenem sodelovanju pri ustanovitvi Evropskega javnega tožilstva –
The proposed citizens' initiative entitled ‘STOP FRAUD and abuse of EU FUNDS — by better control of decisions, implementation and penalties’ is hereby registered.
Predlagana državljanska pobuda z naslovom „USTAVIMO GOLJUFIJE in zlorabo SREDSTEV EU – z boljšim nadzorom nad odločitvami, izvajanjem in kaznimi“ se prijavi.
Statements of support for this proposed citizens' initiative may be collected, based on the understanding that it aims at proposals from the Commission for legal acts of the Union for the purpose of implementing the Treaties which — while enhancing the protection of the financial interests of the Union — do not differentiate between Member States solely according to their participation or non-participation in the enhanced cooperation on the establishment of the European Public Prosecutor's Office.
Izjave o podpori tej predlagani državljanski pobudi bi bilo treba zbrati, v kolikor je njen cilj, da Komisija predlaga pravne akte Unije za izvajanje Pogodb, ki ob krepitvi zaščite finančnih interesov Unije ne razlikujejo med državami članicami izključno glede na njihovo udeležbo ali neudeležbo v okrepljenem sodelovanju pri ustanovitvi Evropskega javnega tožilstva.
This Decision shall enter into force on 27 September 2018.
Ta sklep začne veljati 27. septembra 2018.
This Decision is addressed to the organisers (members of the citizens' committee) of the proposed citizens' initiative entitled ‘STOP FRAUD and abuse of EU FUNDS — by better control of decisions, implementation and penalties’, represented by Mr Zoltán KERESZTÉNY and Mr Balázs FEHÉR acting as contact persons.
Ta sklep je naslovljen na organizatorje (člane državljanskega odbora) predlagane državljanske pobude z naslovom „USTAVIMO GOLJUFIJE in zlorabo SREDSTEV EU – z boljšim nadzorom nad odločitvami, izvajanjem in kaznimi“, ki jih kot kontaktni osebi zastopata Zoltán KERESZTÉNY in Balázs FEHÉR.
Done at Brussels, 19 September 2018.
V Bruslju, 19. septembra 2018
Council Decision (EU) 2018/1474
Sklep Sveta (EU) 2018/1474
appointing two members and four alternate members, proposed by the Republic of Austria, of the Committee of the Regions
o imenovanju dveh članov in štirih nadomestnih članov Odbora regij na predlog Republike Avstrije
Two members' seats on the Committee of the Regions have become vacant following the end of the term of office of Mr Michael HÄUPL and Mr Herwig VAN STAA.
Zaradi konca mandatov Michaela HÄUPLA in Herwiga VAN STAAJA sta se sprostili dve mesti članov Odbora regij.
Three alternate members' seats on the Committee of the Regions have become vacant following the end of the term of office of Ms Renate BRAUNER, Ms Brigitta PALLAUF and Ms Barbara SCHWARZ.
Zaradi konca mandatov Renate BRAUNER, Brigitte PALLAUF in Barbare SCHWARZ so se sprostila tri mesta nadomestnih članov Odbora regij.
An alternate member's seat has become vacant following the appointment of Mr Günther PLATTER as a member of the Committee of the Regions,
Zaradi imenovanja Güntherja PLATTERJA za člana Odbora regij se je sprostilo mesto nadomestnega člana –
The following are hereby appointed to the Committee of the Regions for the remainder of the current term of office, which runs until 25 January 2020:
Za preostanek mandata, ki se izteče 25. januarja 2020, se v Odbor regij imenujejo:
Commission Implementing Decision (EU) 2018/1477
Izvedbeni sklep Komisije (EU) 2018/1477
of 2 October 2018
z dne 2. oktobra 2018
on the terms and conditions of the authorisations of biocidal products containing ethyl butylacetylaminopropionate referred by Belgium in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council
o določilih in pogojih za izdajo dovoljenja za biocidna proizvoda, ki vsebujeta etil butilacetilaminopropionat, ki jih je predložila Belgija v skladu s členom 36 Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta
(notified under document C(2018) 6291)
(notificirano pod dokumentarno številko C(2018) 6291)
On 16 December 2014, the company Merck KGaA (‘the applicant’) submitted an application for mutual recognition in parallel of two insect repellents applied on humans against mosquitoes and ticks containing the active substance ethyl butylacetylaminopropionate in the form of a pump spray and an aerosol, respectively (‘the contested products’) to the competent authority of Belgium (‘the reference Member State’) in accordance with Article 34(1) of Regulation (EU) No 528/2012.
Družba Merck KGaA (v nadaljnjem besedilu: vlagatelj) je 16. decembra 2014 v skladu s členom 34(1) Uredbe (EU) št. 528/2012 pri pristojnem organu Belgije (v nadaljnjem besedilu: referenčna država članica) vložila vlogo za vzporedno medsebojno priznavanje dveh repelentov proti žuželkam, tj. proti komarjem in klopom, za uporabo na ljudeh in ki vsebujeta aktivno snov etil butilacetilaminopropionat v obliki razpršila in aerosola (v nadaljnjem besedilu: sporna proizvoda).
At the same time, the applicant submitted applications for mutual recognition of the contested products to a number of Member States, including the United Kingdom, in accordance with Article 34(2) of that Regulation.
Hkrati je vlagatelj v skladu s členom 34(2) navedene uredbe pri več državah članicah, vključno z Združenim kraljestvom, vložil vloge za medsebojno priznavanje spornih proizvodov.
Pursuant to Article 35(2) of Regulation (EU) No 528/2012, the United Kingdom referred objections to the coordination group on 14 February 2017 and to the applicant, indicating that the contested products do not meet the conditions laid down in Article 19(1)(b) of that Regulation.
V skladu s členom 35(2) Uredbe (EU) št. 528/2012 je Združeno kraljestvo 14. februarja 2017 koordinacijski skupini in vlagatelju predložilo ugovore, pri čemer je navedlo, da sporna proizvoda ne izpolnjujeta pogojev iz člena 19(1)(b) navedene uredbe.
The United Kingdom considers that the assessment of the applications has not been correctly carried out by the reference Member State, since there is a discrepancy between the application rate used in the efficacy studies and the application rate used in the exposure assessment, which is lower (‘the discrepancy’).
Združeno kraljestvo meni, da referenčna država članica ni pravilno ocenila vlog, saj obstaja neskladje med odmerkom, uporabljenim pri študijah učinkovitosti, in odmerkom, uporabljenim pri oceni izpostavljenosti, ki je nižji (v nadaljnjem besedilu: neskladje).
The coordination group secretariat invited the other Member States concerned and the applicant to submit written comments about the referral.
Sekretariat koordinacijske skupine je druge zadevne države članice in vlagatelja pozval k predložitvi pisnih pripomb na ugovor.
Denmark, Germany, Latvia and the applicant submitted comments.
Danska, Nemčija, Latvija in vlagatelj so predložili pripombe.
The referral was also discussed in the coordination group's meetings of 14 March 2017 and 10 May 2017.
O ugovoru se je razpravljalo tudi na sestankih koordinacijske skupine 14. marca 2017 in 10. maja 2017.
As no agreement was reached in the coordination group, the reference Member State referred the unresolved objection to the Commission pursuant to Article 36(1) of Regulation (EU) No 528/2012 on 18 July 2017.
Ker v koordinacijski skupini ni bil dosežen dogovor, je referenčna država članica Komisiji 18. julija 2017 predložila nerešeni ugovor v skladu s členom 36(1) Uredbe (EU) št. 528/2012.
The reference Member State, Austria, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, Latvia, Lithuania, Malta, The Netherlands, Spain and Sweden authorised the relevant contested product in the period from 16 May 2017 to 6 March 2018, pursuant to Article 34(7) of Regulation (EU) No 528/2012.
Referenčna država članica, Avstrija, Bolgarija, Ciper, Češka, Estonija, Finska, Latvija, Litva, Malta, Nizozemska, Španija in Švedska so med 16. majem 2017 in 6. marcem 2018 izdale dovoljenje za zadevni sporni proizvod v skladu s členom 34(7) Uredbe (EU) št. 528/2012.
On 7 September 2017, the Commission requested an opinion from the European Chemicals Agency (‘the Agency’) pursuant to Article 36(2) of Regulation (EU) No 528/2012 on a number of questions concerning the discrepancy.
Komisija je 7. septembra 2017 v skladu s členom 36(2) Uredbe (EU) št. 528/2012 zaprosila Evropsko agencijo za kemikalije (v nadaljnjem besedilu: Agencija) za mnenje o številnih vprašanjih v zvezi z neskladjem.
The Agency (the Biocidal Products Committee) adopted its opinion on 12 December 2017.
Agencija (Odbor za biocidne proizvode) je mnenje sprejela 12. decembra 2017.
According to the Agency, the approach followed by the reference Member State, namely to accept the discrepancy, is not appropriate when verifying whether the conditions in Article 19(1)(b) of Regulation (EU) No 528/2012 are satisfied.
Po mnenju Agencije pristop referenčne države članice, in sicer da sprejme neskladje, ni ustrezen pri preverjanju, ali so pogoji iz člena 19(1)(b) Uredbe (EU) št. 528/2012 izpolnjeni.
The Agency considers that either the available information is not sufficient to demonstrate that the contested products, when used at the lower application rates, are sufficiently effective or unacceptable effects on the health of humans are identified, when the contested products are used at the higher application rates derived from the efficacy studies.
Agencija meni, da razpoložljive informacije ne zadostujejo za dokaz, da sta sporna proizvoda, kadar se uporabljata v nižjih odmerkih, dovolj učinkovita, ali da se ugotovijo nesprejemljivi učinki na zdravje ljudi, kadar se sporna proizvoda uporabljata v višjih odmerkih, ki izhajajo iz študij učinkovitosti.
The Agency emphasises in its opinion the general principle that the application rate proven efficacious should be considered for the exposure assessment.
Agencija v svojem mnenju poudarja splošno načelo, da je treba pri oceni izpostavljenosti upoštevati dokazano učinkovit odmerek.
Using the application rate derived from the efficacy studies in the exposure assessment for the contested products results in an unacceptable risk for human health with regard to a number of the intended uses.
Uporaba odmerka, ki izhaja iz študij učinkovitosti, v oceni izpostavljenosti za sporna proizvoda povzroča nesprejemljivo tveganje za zdravje ljudi v zvezi z več predvidenimi uporabami.
In light of the opinion of the Agency, the condition laid down in Article 19(1)(b)(iii) of Regulation (EU) No 528/2012 cannot be considered to be met for any of the intended uses of the aerosol contested product, nor for the intended use of the pump spray contested product for infants under one year of age.
Glede na mnenje Agencije pogoja iz člena 19(1)(b)(iii) Uredbe (EU) št. 528/2012 ni mogoče šteti za izpolnjenega za nobeno predvideno uporabo spornega proizvoda v obliki aerosola niti za nobeno predvideno uporabo spornega proizvoda v obliki razpršila pri dojenčkih, mlajših od enega leta.
Such uses can therefore only be authorised in accordance with Article 19(5) of that Regulation in those Member States in which the condition laid down in the first subparagraph of Article 19(5) is met.
Zato se lahko takšne uporabe odobrijo samo v skladu s členom 19(5) navedene uredbe v tistih državah članicah, v katerih je izpolnjen pogoj iz prvega pododstavka člena 19(5).
However, pursuant to point 77 of Annex VI to Regulation (EU) No 528/2012, the recommended application rate should be the minimum necessary to achieve the desired effect.
Vendar mora biti v skladu s točko 77 Priloge VI k Uredbi (EU) št. 528/2012 priporočeni odmerek minimalen odmerek, ki je potreben, da se doseže želeni učinek.
An unnecessarily high application rate would be inconsistent with the principle of proper use referred to in the second subparagraph of Article 17(5) of that Regulation.
Nepotrebno visok odmerek bi bil v neskladju z načelom pravilne uporabe iz drugega pododstavka člena 17(5) navedene uredbe.
The Agency also points out in its opinion that there is no precise agreed Union guidance on how to generate efficacy data for insect repellents when using the recommended application rates.
Agencija v svojem mnenju navaja tudi, da ni natančnih dogovorjenih smernic Unije o tem, kako pridobiti podatke o učinkovitosti za repelenta proti žuželkam pri uporabi priporočenih odmerkov.
Work on developing such Union guidance has already started but time to conclude is needed in order to enable applicants to generate data to demonstrate the efficacy of a product in a predictable manner.
Delo v zvezi z razvojem takih smernic Unije se je že začelo, vendar je potreben čas za njihov zaključek in da bi se vlagateljem omogočilo, da na predvidljiv način pridobijo podatke za dokazovanje učinkovitosti proizvoda.
The Agency refers in its opinion to an agreement reached by the coordination group in accordance with Article 35(3) of Regulation (EU) No 528/2012 on certain other insect repellents containing a different active substance.
Agencija se v svojem mnenju sklicuje na dogovor, ki je bil v koordinacijski skupini v skladu s členom 35(3) Uredbe (EU) št. 528/2012 dosežen o nekaterih drugih repelentih proti žuželkam, ki vsebujejo drugačno aktivno snov.
For those products, the discrepancy was accepted by all Member States concerned under the condition that it would be addressed when the product authorisations are renewed and new Union guidance is available.
Za navedene proizvode so to neskladje sprejele vse zadevne države članice pod pogojem, da bo obravnavano, ko bodo dovoljenja za proizvod obnovljena in bodo na voljo nove smernice Unije.
It is also mentioned in the opinion that this precedent may have led to a misunderstanding by the applicant and the reference Member State regarding the efficacy data requirements for insect repellents.
Prav tako je v mnenju navedeno, da je ta precedens lahko privedel do nesporazuma pri vlagatelju in referenčni državi članici glede zahtev v zvezi s podatki o učinkovitosti repelentov proti žuželkam.
Pursuant to Article 22(1) of Regulation (EU) No 528/2012, an authorisation of a biocidal product shall stipulate the terms and conditions relating to the making available on the market and use of the product.
V skladu s členom 22(1) Uredbe (EU) št. 528/2012 mora dovoljenje za biocidni proizvod določati določila in pogoje v zvezi z dostopnostjo na trgu in uporabo proizvoda.
Those terms and conditions may include a requirement for the authorisation holder to provide additional information and, where relevant, to submit an application for a change of the authorisation in accordance with Commission Implementing Regulation (EU) No 354/2013 within a given deadline.
Navedeni določila in pogoji vključujejo zahtevo za imetnika dovoljenja, da v določenem roku zagotovi dodatne informacije in po potrebi vloži vlogo za spremembo dovoljenja v skladu z Izvedbeno uredbo Komisije (EU) št. 354/2013.
It is necessary to maintain sufficient availability of insect repellents containing different active substances to minimise the occurrence of resistance in the target harmful organisms and a level playing field with regard to the generation of efficacy data at the recommended application rate should apply for all applicants and/or authorisation holders, irrespective of the involved active substances in their products.
Treba je ohraniti zadostno razpoložljivost repelentov proti žuželkam, ki vsebujejo različne aktivne snovi, da se čim bolj zmanjša pojav odpornosti pri ciljnih škodljivih organizmih, za vse vlagatelje in/ali imetnike dovoljenj pa bi se morali uporabljati enaki konkurenčni pogoji glede pridobivanja podatkov o učinkovitosti pri priporočenem odmerku, ne glede na to, katera od teh aktivnih snovi se uporablja v njihovih proizvodih.
The recommended application rate should be the minimum necessary to achieve the desired effect of the insect repellent in accordance with the principle of proper use.
Priporočeni odmerek bi moral biti minimalni odmerek, ki je potreben, da se doseže želeni učinek repelenta proti žuželkam v skladu z načelom pravilne uporabe.
Consequently, authorisations of the contested products should include a condition that the authorisation holder provides new data to confirm the efficacy of the products at the proposed application rate when Union guidance on how to generate efficacy data at the recommended application rates has been published by the Agency.
Zato bi morala dovoljenja za sporna proizvoda vključevati pogoj, da imetnik dovoljenja zagotovi nove podatke za potrditev učinkovitosti proizvodov pri predlaganem odmerku, ko Agencija objavi navodila Unije glede pridobivanja podatkov o učinkovitosti pri priporočenih odmerkih.
The authorisation holder should be allowed sufficient time to generate the new data in accordance with that guidance.
Imetnik dovoljenja bi moral imeti na voljo dovolj časa za pridobitev novih podatkov v skladu z navedenimi smernicami.
This Decision applies to the biocidal products identified by the asset numbers BE-0012319-0000 and BE-0012317-0000 in the Register for Biocidal Products.
Ta sklep se uporablja za biocidna proizvoda, opredeljena s zadevnima številkama BE-0012319–0000 in BE-0012317–0000 v registru biocidnih proizvodov.
When applying the application rate derived from the efficacy studies, the biocidal products referred to in Article 1 meet the condition laid down in Article 19(1)(b)(i) of Regulation (EU) No 528/2012 but not the condition laid down in Article 19(1)(b)(iii) of that Regulation for all intended uses.
Pri uporabi odmerka, ki izhaja iz študij učinkovitosti, biocidna proizvoda iz člena 1 izpolnjujeta pogoj iz člena 19(1)(b)(i) Uredbe (EU) št. 528/2012, ne pa tudi pogoja iz člena 19(1)(b)(iii) navedene uredbe za vse predvidene uporabe.